PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-38.37%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-62.05%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-71.04%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-71.04%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-69.69%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-69.70%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-69.64%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
-0.13%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.33%
Dividend growth under 50% of OBE's 3.29%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-33.19%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-73.31%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
415.69%
Positive 10Y revenue/share CAGR while OBE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
344.68%
Positive 5Y CAGR while OBE is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
161.95%
Positive 3Y CAGR while OBE is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
438.64%
Positive long-term OCF/share growth while OBE is negative. John Neff would see a structural advantage in sustained cash generation.
372.62%
Positive OCF/share growth while OBE is negative. John Neff might see a comparative advantage in operational cash viability.
-21.13%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
1378.39%
Positive 10Y CAGR while OBE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
417.65%
Positive 5Y CAGR while OBE is negative. John Neff might view this as a strong mid-term relative advantage.
-39.82%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
518.48%
10Y equity/share CAGR above 1.5x OBE's 64.23%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
246.88%
5Y equity/share CAGR above 1.5x OBE's 64.23%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
89.84%
3Y equity/share CAGR 1.25-1.5x OBE's 64.23%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
2016.49%
10Y dividend/share CAGR above 1.5x OBE's 3.19%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
5483.84%
5Y dividend/share CAGR above 1.5x OBE's 3.19%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
518.27%
3Y dividend/share CAGR above 1.5x OBE's 3.19%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-23.94%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-59.38%
Inventory is declining while OBE stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-6.43%
Negative asset growth while OBE invests at 1.09%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.83%
We have a declining book value while OBE shows 0.92%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
22.83%
Debt growth far above OBE's 3.74%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
311.11%
SG&A growth well above OBE's 22.37%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.